Showing 341 - 360 results of 521 for search '"Hepatitis B"', query time: 0.07s Refine Results
  1. 341

    Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease by Shi-Chun Lu, Tao Jiang, Wei Lai, Yuan Liu, Jing Zhang, Dao-Bing Zeng, Chuan-Yun Li, Meng-Long Wang, Dong-Dong Lin, Yue Zhu, You-Ping Li, Ning Li

    Published 2014-01-01
    “…The aim of this study was to establish a hepatitis B virus (HBV) vaccination protocol among orthotopic liver transplantation (OLT) recipients under the coverage of a low-dose hepatitis B immunoglobulin (HBIG) combined with an antiviral agent prophylaxis protocol. …”
    Get full text
    Article
  2. 342
  3. 343

    Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases by Yanqiang Liao, Se Peng, Lesheng Huang, Zhong Li, Jian Hu, Rui Xu, Wenzhi Tang, Jialing Zhuang

    Published 2024-01-01
    “…To evaluate its clinical application, serum CHI3L1 levels were detected in 82 patients with chronic hepatitis B (CHB) and in 21 healthy controls. The patients with CHB and HCC had higher CHI3L1 levels than the healthy controls and the patients with CHB without HCC. …”
    Get full text
    Article
  4. 344

    Social Media Recruitment as a Potential Trigger for Vulnerability: Multistakeholder Interview Study by Nina Matthes, Theresa Willem, Alena Buyx, Bettina M Zimmermann

    Published 2024-12-01
    “…We triangulated the expert assessments with the perceptions of 6 patients with hepatitis B regarding social media usage and attitudes relative to their diagnosis. …”
    Get full text
    Article
  5. 345

    Potential link between transfusion-transmitted infections and ABO and Rh blood group systems in healthy blood donors by Aneesha Kataria, Durre Aden, Sabina Khan, Meesa Mehraj, Yasir Alvi, Sujata Jetley

    Published 2024-12-01
    “…TTI positivity was identified in 1.79% of donors, with the following breakdown: 69.27% positive for hepatitis B, 15.6% for hepatitis C, 11.7% for HIV, and 5% for syphilis. …”
    Get full text
    Article
  6. 346

    Serology of Viral Infections and Tuberculosis Screening in an IBD Population Referred to a Tertiary Centre of Southern Italy by Marco Ardesia, Giuseppe Costantino, Placido Mondello, Angela Alibrandi, Walter Fries

    Published 2017-01-01
    “…The aim of our study was to assess the immune status for hepatitis B, varicella, mononucleosis, and cytomegalovirus infection together with the determination of the hepatitis C and tuberculosis status in Southern Italy. …”
    Get full text
    Article
  7. 347

    HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients’ clinical stage by Lucile Dumolard, Theophile Gerster, Florent Chuffart, Thomas Decaens, Marie-Noelle Hilleret, Sylvie Larrat, Philippe Saas, Evelyne Jouvin-Marche, David Durantel, Patrice N. Marche, Zuzana Macek Jilkova, Caroline Aspord

    Published 2025-02-01
    “…Background:. Hepatitis B is a liver infection caused by HBV. Infected individuals who fail to control the viral infection develop chronic hepatitis B and are at risk of developing life-threatening liver diseases, such as cirrhosis or liver cancer. …”
    Get full text
    Article
  8. 348

    STING modulates HBV-related acute-on-chronic liver failure by mediating autophagy and macrophage polarization by Hao Zhang, Teng Liang, Wanlu Duan, Futing Liu, LiPing Li, Qian Liu, Jianfei Li, Qiyin Zong, Lei Jin, Qin Wang, Qiang Zhou

    Published 2025-01-01
    “…Presently, there is a paucity of experimental models that specifically focus on HBV-ACLF based on chronic hepatitis B. Therefore, this study aimed to establish an experimental mouse model of HBV-ACLF using chronic hepatitis B (CHB) as a basis and investigate the impact of STING activation on the disease. …”
    Get full text
    Article
  9. 349

    Virological outcomes of antiretroviral therapy and its determinants among HIV patients in Ethiopia: Implications for achieving the 95-95-95 target. by Tegene Atamenta Kitaw, Ribka Nigatu Haile

    Published 2025-01-01
    “…To improve virological outcomes, it is crucial to increase support for low-income patients, enhance management of co-infections like TB and hepatitis B, and expand access to HIV support groups for better adherence and care.…”
    Get full text
    Article
  10. 350

    Hepatitis C pada Anak by Yusri Dianne Jurnalis, Yorva Sayoeti, Adria Russelly

    Published 2014-05-01
    “…Infeksi HCV akut dapat berakhir dengan sirosis dan karsinoma hepatoselular setelah dekade ketiga (sekitar 20%), karena progresivitas infeksi HCV lebih lambat dari infeksi hepatitis B virus. Pada umumnya infeksi HCV bersifat asimptomatik termasuk pada anak. …”
    Get full text
    Article
  11. 351

    Fever, uveitis, and myocarditis as the initial presentation of Behcet's Disease: A case report and review of the literature by Vishal Mangal, Yogendra Mishra, Amar Tej Atal, Divya Kochhar, Durga Madhab Tripathy, Manish Manrai

    Published 2021-01-01
    “…She also had persistent transaminitis, and on evaluation, she was found to have occult hepatitis B infection with possible reactivation. The final diagnosis of BD with myocarditis and occult hepatitis B infection was established. …”
    Get full text
    Article
  12. 352

    Management of patients with dry eye syndrome with systemic autoimmune and infectious diseases by G.M. Chernakova, E.A. Kleshcheva

    Published 2018-07-01
    “…<br> <br> <b>Key words:</b> dry eye syndrome, systemic autoimmune diseases, human immunodeficiency virus, hepatitis B virus, hepatitis C virus, Epstein-Barr virus, antioxidant therapy, Artelac Splash, Artelac Balance.…”
    Get full text
    Article
  13. 353

    Awareness of medical students about standard isolation precautions In Sulaimani City by Bushra M. Ali, Saman A. Mohammed, Balen Tayb Abdullah, Osama Muhammed, Mutasam Fabian, Muhammed Rauf

    Published 2019-09-01
    “…The percentage of the students that have taken a vaccine for Hepatitis B is (56.4%). Most of students had good knowledge regarding all aspects of Isolation Precaution, they had appropriate attitude toward it, high rate of medical students were lacking practice regarding the subject, in average college of Nursing had highest rate of all correct answers, About half of medical students have taken a vaccine for Hepatitis B. …”
    Get full text
    Article
  14. 354

    Acute hepatitis of non-specified etiology by Ye. V. Tsyganova, O. O. Znoyko, N. D. Yushchuk, K. R. Dudina, M. G. Isagulyants, N. V. Petrakova, T. V. Petrova, M. I. Mikhaylov

    Published 2011-02-01
    “…Thirty three patients with acute hepatitis C and 36 patients with acute hepatitis B made groups of comparison, control group included 15 healthy persons. …”
    Get full text
    Article
  15. 355

    Primary prevention of sexually transmitted infections in Switzerland: practices of family physicians and their determinants—a national cross-sectional survey by Hanna Vautrin, Nicolas Senn, Christine Cohidon

    Published 2020-09-01
    “…Vaccinating children against hepatitis B is associated with practising in rural areas (OR 4.64 (1.20 to 17.98)). …”
    Get full text
    Article
  16. 356

    Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning by Shuxian Pan, Zibing Wang

    Published 2025-01-01
    “…BackgroundImmune checkpoint inhibitors have proven efficacy against hepatitis B-virus positive hepatocellular. However, Immunotherapy-related adverse reactions are still a major challenge faced by tumor immunotherapy, so it is urgent to establish new methods to effectively predict immunotherapy-related adverse reactions.ObjectiveMulti-machine learning model were constructed to screen the risk factors for irAEs in ICIs for the treatment of HBV-related hepatocellular and build a prediction model for the occurrence of clinical IRAEs.MethodsData from 274 hepatitis B virus positive tumor patients who received PD-1 or/and CTLA4 inhibitor treatment and had immune cell detection results were collected from Henan Cancer Hospital for retrospective analysis. …”
    Get full text
    Article
  17. 357

    Timosin alpha-1 immunomodulating properties by M. V. Mayevskaya

    Published 2009-02-01
    “…Timosin alpha-1 can be applied at immune antineoplastic therapy, in particular in treatment of hepatocellular carcinoma which is related to a final stage of persistent infection of hepatitis B and C viruses, that, as a rule, develops on a background of liver cirrhosis and in Caucasian patients.Conclusion. …”
    Get full text
    Article
  18. 358

    Hepatocellular carcinoma in a sheep by Zabid Yener, Hüdaverdi Erer

    “…Immunohistochemically. some tumour markers, such as carcinoembryonic antigen (CEA), alpha-letoprotein (AFP), of the intermediate filament proteins, cylokeralin, and superficial antigens of hepatitis B virus was investigated, and alpha-letoprotein (AFP) was founded to be positive.…”
    Get full text
    Article
  19. 359

    Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007 by Lily Fang, Amanda Yu, Jane A. Buxton

    Published 2011-01-01
    “…BACKGROUND: In British Columbia (BC), hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccines are provincially funded for persons with chronic hepatitis infections. …”
    Get full text
    Article
  20. 360